从相关性到因果关系:在阿尔茨海默氏病中细胞类型特定的基因调控网络
Danni Liu1,2, Zhongli Jiang1, Hyunjin Kim3
1Department of Epidemiology and Biostatistics, University of California, Irvine, CA, 92617.
bioRxiv : the preprint server for biology
|October 3, 2025
概括
这项研究绘制了阿尔茨海默病 (AD) 中细胞类型特定基因网络的地图,揭示了关键的调节基因和途径. 这些发现为了解AD复杂的细胞机制和开发新假设提供了资源.
科学领域:
- 神经科学是一个神经科学.
- 基因组学就是基因组学.
- 计算生物学 计算生物学
背景情况:
- 阿尔茨海默氏病 (AD) 涉及多种脑细胞类型的复杂调控干扰.
- 驱动AD病变的细胞内因果机制尚不清楚.
研究的目的:
- 在人类AD中构建全面的,细胞类型特定的基因调控网络 (GRNs).
- 为了识别潜在的AD病理的因果调节基因和途径.
主要方法:
- 集成的单核转录基因数据与ROSMAP研究中的基因型数据 (n=272).
- 开发了一个基于因果关系的框架来构建特定于细胞类型的GRNs.
- 鉴定了参与基因调节的转录因子 (TF) 和非TF.
主要成果:
- 在AD中生成了跨多种脑细胞类型的完整因果调节图.
- 发现了已知的和新的调节元件,通路和细胞类型独特的枢纽基因.
- 在定量上区分了枢纽基因的调节和响应作用.
结论:
- 提供了AD中细胞类型特定的因果GRN的全面映射.
- 建立了一个有价值的资源,用于探索动态途径,并在AD研究中产生假设.
- 促进了AD相关遗传变异的功能解释.
更多相关视频
04:41Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration
Published on: January 9, 2020
19.3K
09:33Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
Published on: December 26, 2016
8.4K
相关概念视频
Neural Regulation
43.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.1K
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Alzheimer's Disease: Treatment
824
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
824
